Tuis600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Vorige sluiting
¥3,84
Dagwisseling
¥3,82 - ¥3,87
Jaarwisseling
¥2,83 - ¥4,97
Markkapitalisasie
9,67 mjd CNY
Gemiddelde volume
49,65 m
P/V-verhouding
14,62
Dividend-opbrengs
-
Primêre beurs
SHA
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 4,17 mjd | 0,78% |
Bedryfskoste | 844,30 m | -9,24% |
Netto inkomste | 212,93 m | 20,48% |
Netto winsgrens | 5,10 | 19,44% |
Wins per aandeel | — | — |
EBITDA | 322,56 m | 3,64% |
Effektiewe belastingkoers | 19,49% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,80 mjd | -1,58% |
Totale bates | 14,09 mjd | -0,38% |
Totale aanspreeklikheid | 7,79 mjd | -8,76% |
Totale ekwiteit | 6,31 mjd | — |
Uitstaande aandele | 2,52 mjd | — |
Prys om te bespreek | 1,74 | — |
Opbrengs op bates | 4,68% | — |
Opbrengs op kapitaal | 8,65% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 212,93 m | 20,48% |
Kontant van bedrywe | -464,57 m | -71,56% |
Kontant van beleggings | -17,57 m | -19,17% |
Kontant van finansiering | -271,12 m | -314,72% |
Netto kontantverandering | -753,69 m | -372,72% |
Beskikbare kontantvloei | -538,39 m | -13,57% |
Meer oor
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Gestig
1988
Webwerf
Werknemers
10 180
